The Shaping of Cancer by the Tumour Microenvironment and Its Relevance for Cancer Therapy
In this book, we present a compilation of original research articles as well as review articles that are focused on improving our understanding of the molecular and cellular mechanisms by which cancer cells adapt to their microenvironment. These include the interplay between cancer cells and the sur...
Saved in:
| Other Authors: | |
|---|---|
| Format: | Book Chapter |
| Published: |
Basel, Switzerland
MDPI - Multidisciplinary Digital Publishing Institute
2021
|
| Subjects: | |
| Online Access: | Get Fullteks DOAB: description of the publication |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| LEADER | 04708naaaa2201321uu 4500 | ||
|---|---|---|---|
| 001 | doab_20_500_12854_76822 | ||
| 005 | 20220111 | ||
| 020 | |a books978-3-0365-1607-3 | ||
| 020 | |a 9783036516080 | ||
| 020 | |a 9783036516073 | ||
| 024 | 7 | |a 10.3390/books978-3-0365-1607-3 |c doi | |
| 041 | 0 | |a English | |
| 042 | |a dc | ||
| 072 | 7 | |a M |2 bicssc | |
| 100 | 1 | |a Madureira, Patrícia Alexandra Saraiva |4 edt | |
| 700 | 1 | |a Madureira, Patrícia Alexandra Saraiva |4 oth | |
| 245 | 1 | 0 | |a The Shaping of Cancer by the Tumour Microenvironment and Its Relevance for Cancer Therapy |
| 260 | |a Basel, Switzerland |b MDPI - Multidisciplinary Digital Publishing Institute |c 2021 | ||
| 300 | |a 1 electronic resource (307 p.) | ||
| 506 | 0 | |a Open Access |2 star |f Unrestricted online access | |
| 520 | |a In this book, we present a compilation of original research articles as well as review articles that are focused on improving our understanding of the molecular and cellular mechanisms by which cancer cells adapt to their microenvironment. These include the interplay between cancer cells and the surrounding microenvironmental cells (e.g., macrophages, tumor-infiltrating lymphocytes and myeloid cells) and microenvironmental environments (e.g., oxidative stress, pH, hypoxia) and the implications of this dynamic interaction to tumor radioresistance, chemoresistance, invasion and metastasis. Finally, the importance and relevance of these findings are translated to cancer therapy. | ||
| 540 | |a Creative Commons |f https://creativecommons.org/licenses/by/4.0/ |2 cc |4 https://creativecommons.org/licenses/by/4.0/ | ||
| 546 | |a English | ||
| 650 | 7 | |a Medicine |2 bicssc | |
| 653 | |a hypoxia | ||
| 653 | |a macrophages | ||
| 653 | |a colon cancer | ||
| 653 | |a tumor microenvironment | ||
| 653 | |a immune cell infiltration | ||
| 653 | |a prognosis | ||
| 653 | |a feline mammary carcinoma | ||
| 653 | |a PD-1 | ||
| 653 | |a PD-L1 | ||
| 653 | |a CTLA-4 | ||
| 653 | |a TNF-α | ||
| 653 | |a biomarkers | ||
| 653 | |a immunotherapy | ||
| 653 | |a cancer | ||
| 653 | |a histone modification | ||
| 653 | |a inhibitor | ||
| 653 | |a KDM5B | ||
| 653 | |a molecular docking | ||
| 653 | |a repurposing | ||
| 653 | |a cancer acidity | ||
| 653 | |a hyperosmolarity | ||
| 653 | |a cross-presentation | ||
| 653 | |a tumour microenvironment | ||
| 653 | |a syngeneic model | ||
| 653 | |a prostate cancer | ||
| 653 | |a radiotherapy | ||
| 653 | |a preclinical modelling | ||
| 653 | |a myeloid-derived suppressor cells | ||
| 653 | |a biomarker | ||
| 653 | |a stroma | ||
| 653 | |a cancer-associated fibroblast (CAF) | ||
| 653 | |a extracellular matrix (ECM) | ||
| 653 | |a cytokine/chemokine | ||
| 653 | |a growth factors | ||
| 653 | |a pro- and anti-tumor immune cells | ||
| 653 | |a immunomodulatory roles | ||
| 653 | |a radiotherapy dose fractionation | ||
| 653 | |a radioresistance | ||
| 653 | |a radiosensitivity | ||
| 653 | |a breast cancer | ||
| 653 | |a S100A10 (p11) | ||
| 653 | |a tumor growth | ||
| 653 | |a tumor progression | ||
| 653 | |a metastasis | ||
| 653 | |a carcinoma | ||
| 653 | |a mammary gland | ||
| 653 | |a triple negative | ||
| 653 | |a pre-metastatic niche | ||
| 653 | |a pro-inflammatory cytokines | ||
| 653 | |a clinical trials | ||
| 653 | |a evolutionary therapy | ||
| 653 | |a darwinian evolution | ||
| 653 | |a cancer cells subpopulations | ||
| 653 | |a diclofenac | ||
| 653 | |a koningic acid | ||
| 653 | |a spheroid | ||
| 653 | |a 3D co-culture | ||
| 653 | |a microenvironment | ||
| 653 | |a resistance | ||
| 653 | |a myeloid cells | ||
| 653 | |a cancer development | ||
| 653 | |a molecular subtypes of pancreatic cancer | ||
| 653 | |a chemotherapy response | ||
| 653 | |a pancreatic stellate cells | ||
| 653 | |a regulatory T cells | ||
| 653 | |a tumor-associated macrophages | ||
| 653 | |a myeloid derived suppressor cells | ||
| 653 | |a glioblastoma (GB) | ||
| 653 | |a Hypoxia Inducible Factor (HIF) | ||
| 653 | |a glioma stem cells (GSC) | ||
| 653 | |a oxidative stress | ||
| 653 | |a reactive oxygen species | ||
| 653 | |a plasmin | ||
| 653 | |a plasminogen | ||
| 653 | |a S100A10 | ||
| 653 | |a uPA | ||
| 653 | |a uPAR | ||
| 653 | |a PAI-1 | ||
| 653 | |a PAI-2 | ||
| 653 | |a cancer stem cells | ||
| 653 | |a cancer recurrence | ||
| 653 | |a therapeutic resistance | ||
| 653 | |a signaling pathways | ||
| 653 | |a targeted therapy | ||
| 653 | |a head and neck cancer | ||
| 653 | |a lung cancer | ||
| 653 | |a bladder cancer | ||
| 856 | 4 | 0 | |a www.oapen.org |u https://mdpi.com/books/pdfview/book/4271 |7 0 |z Get Fullteks |
| 856 | 4 | 0 | |a www.oapen.org |u https://directory.doabooks.org/handle/20.500.12854/76822 |7 0 |z DOAB: description of the publication |